Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Board Meeting Outcome for Outcome Of Board Meeting Dated 24Th June, 2022

1) Approved the raising of funds, through issuance and allotment of equity shares having face value of ? 1 each up to an aggregate amount of ? 400 Crores (Rupees Four Hundred Crores) on rights basis and on such terms (as decided by the Board or a duly constituted committee of the Board, at a later date) to the eligible equity shareholders of the Company, as on the record date (to be notified subsequently), subject to receipt of regulatory/ statutory approvals, in accordance with the applicable laws including the provisions of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, SEBI LODR Regulations and the Companies Act, 2013, and rules and regulations made thereunder, each as amended from time to time and approved other related matters including the constitution of a Rights Issue Committee to implement the proposal of Rights Issue.
24-06-2022

Suven Life freezes at 20% upper circuit as board to mull rights issue

The stock had hit a 52-week low of Rs 62 on June 20, 2022, and has corrected 50 per cent from its record high level of Rs 124 touched on October 8, 2021
21-06-2022
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Board to consider Right Issue of equity shares

Suven Life Sciences Ltd has informed BSE that a meeting of the Board of Directors of the Company is scheduled to be held on June 24, 2022, inter alia, to consider matters related to raising of funds through issue of equity shares of the Company on rights basis to the existing equity shareholders of the Company in accordance with provisions of Companies Act, 2013 and SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended and other matters related/ incidental thereto including the constitution of a Committee of Board of Directors namely 'Rights Issue Committee' to implement the proposal of Rights Issue.In this connection, in compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended and in terms of the Code of Conduct of the Company for prevention of Insider Trading, the "Trading Window" for dealing in the securities of theCompany shall remain closed from 21st June 2022 to 26th June 2022 (both days inclusive) for the Directors, Promoters, other Designated Persons, and immediate relatives of Designated Persons covered under the said code read with the SEBI Regulations,. Further, Trading window will be opened from 27th June, 2022.
20-06-2022
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Board Meeting Intimation for Prior Intimation Of Board Meeting Of Suven Life Sciences Limited Under Regulation 29(1)(D) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015,

SUVEN LIFE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/06/2022 ,inter alia, to consider and approve With reference to above subject and pursuant to Regulation 29(1)(d) of the SEBI LODR Regulations, this is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, 24th June, 2022 at 11:00 a.m., inter alia, to consider matters related to raising of funds through issue of equity shares of the Company on rights basis to the existing equity shareholders of the Company in accordance with provisions of Companies Act, 2013 and SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended and other matters related/ incidental thereto including the constitution of a Committee of Board of Directors namely 'Rights Issue Committee' to implement the proposal of Rights Issue. The "Trading Window" for dealing in the securities of the Company shall remain closed from 21st June 2022 to 26th June 2022 (both days inclusive) for the Directors, Promoters, other Designated Persons, and immediate relatives of Designated Persons.
20-06-2022
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform that the Company has received intimation from the following shareholders(s) regarding loss of share certificate(s) as detailed below. A copy of intimation letter enclosed herewith.
16-06-2022
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Announcement under Regulation 30 (LODR)-Newspaper Publication

With reference to above subject, please find enclosed the copies of the newspaper advertisements, in connection with the subject referred above as required under Rule 6 (3) of the Investor Education and Protection Fund Authority (Accounting, Audit, Transfer and Refund) Rules, 2016 read with the provisions of Companies Act, 2013 as appeared today i.e. June 03, 2022 in Business Standard and Nava Telangana (Telugu). The above information will also be hosted on the website of the Company at the following web link: http://www.suven.com/unpaiddividend.aspx
03-06-2022
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Compliances-Reg.24(A)-Annual Secretarial Compliance

With reference to above subject, please find enclosed herewith the Annual Secretarial Compliance Report of the Company from M/s. D. Renuka, Practicing Company Secretary, for the Financial Year ended 31st March, 2022, in terms of Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD1/27/2019 dated 8th February, 2019.
24-05-2022
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Disclosure Of Related Party Transactions Pursuant To Regulation 23(9)

Pursuant to Regulation 23(9) of Listing Regulations, please find enclosed disclosure of related party transactions and balances for the half year ended March 31st, 2022.
20-05-2022
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Book Closure For The Purpose Of AGM

Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements), 2015, the Register of Member and Share Transfer Books of the Company will remain closed from 02nd August, 2022 to 04th August, 2022 (both days inclusive) for taking record of the Members of the Company for the purpose of 33rd Annual General Meeting of the Company.
10-05-2022
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, lease find enclosed the copies of the newspaper advertisement regarding Audited Financial Results of the Company for quarter and Financial Year ended 31st March, 2022. The advertisements are as appeared on 9th May, 2022 in Business Standard and Andhra Prabha (Telugu).
09-05-2022
Next Page
Close

Let's Open Free Demat Account